Table 1. Baseline and follow-up characteristics of up to 17394 participants in EpiDREAM by glycemic status.
| Category | NGT | IFG/IGT | T2D | All | P- value | |
|---|---|---|---|---|---|---|
| Total at baseline N (%) | 7447 (42.8%) | 7389 (42.5%) | 2558 (14.7%) | 17394 (100%) | ||
| Gender N (%) | Male | 2496 (33.5%) | 3119 (42.2%) | 1169 (45.7%) | 6784 (39.1%) | 1.34 × 10−38 |
| Female | 4951 (66.5%) | 4270 (57.8%) | 1389 (54.3%) | 10610 (60.9%) | ||
| aAge (years) | 49.38 (11.08) | 54.90 (10.98) | 55.79 (10.89) | 52.66 (11.38) | 1.44 × 10−247 | |
| aFPG (mmol/L) | 4.85 (0.51) [7444] | 5.86 (0.57) [7389] | 7.54 (2.16) [2556] | 5.67 (1.32) [17389] | 0 | |
| a2hPG (mmol/L) | 5.51 (1.19) [7419] | 7.81 (1.83) [7388] | 13.23 (3.95) [2424] | 7.58 (3.26) [17231] | 0 | |
| aBMI at baseline (kg/m2) | 28.98 (6.04) [7437] | 30.95 (6.12) [7380] | 31.28 (6.34) [2556] | 30.16 (6.20) [17373] | 2.22 × 10−104 | |
| aBMI at follow-up (kg/m2) | 29.34 (6.09) [3577] | 31.42 (6.35) [4740] | 31.05 (6.18) [980] | 30.58 (6.31) [9297] | 1.06 × 10−50 | |
| aBMI Change (kg/m2) | 0.36 (2.83) [3555] | 0.22 (2.54) [4683] | −0.52 (2.61) [971] | 0.20 (2.67) [9209] | 5.19 × 10−19 | |
| Ethnic groups N (%) | 5.86 × 10−76 | |||||
| South Asian | 1556 (20.9%) | 756 (10.2%) | 444 (17.4%) | 2756 (15.8%) | ||
| East Asian | 74 (1.0%) | 100 (1.4%) | 51 (2.0%) | 225 (1.3%) | ||
| European | 3671 (49.3%) | 4355 (58.9%) | 1354 (52.9%) | 9380 (53.9%) | ||
| African | 465 (6.2%) | 557 (7.5%) | 225 (8.8%) | 1247 (7.2%) | ||
| Latin American | 1460 (19.6%) | 1402 (19.0%) | 425 (16.6%) | 3287 (18.9%) | ||
| Native-North American | 221 (3.0%) | 219 (3.0%) | 59 (2.3%) | 499 (2.9%) | ||
NGT = Normal glucose tolerance; IFG = Impaired fasting glucose; IGT = Impaired glucose tolerance; T2D = Type 2 Diabetes; BMI = Body mass Index; FPG = fasting plasma glucose; 2hPG = two hour plasma glucose; SD = standard deviation; N = sample size.
aData are presented as mean (SD) [N].